CDK-TCIP2 , CAS No.C1425528

CAS: C1425528 Cat. No.: C1425528 Formula: C52H67ClN12O8S2 Peso molecolare: 1087.75
Disponibile su ordine
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
1mg
C1425528-1mg
Su ordinazione · 8–12 settimane
Enter a quantity for the sizes you want to add.

Panoramica

DK-TCIP2, linking inhibitor of CDK9 SNS-032 with ligands of BCL6 BI-3812 , is a anticancer agent. DK-TCIP2 shows anticancer activity in vivo and in vitro and can be used for study of lymphoma cancer.

Specifiche

Condizioni di conservazione di stoccaggio
Store at -20°C
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Tipo di azione
INHIBITOR
Nomi e identificatori
Peso molecolare
1087.75

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No vendor-tested application protocols are provided for this item. The following general procedures are commonly used for small molecules in research and should be optimized by the user.

General stock preparation (research use only):

  • Allow vial to equilibrate to room temperature in a desiccator before opening to minimize moisture uptake.
  • Prepare a concentrated stock in DMSO (e.g., 10–50 mM), vortex until dissolved, and, if needed, sonicate briefly. Filter through a 0.22 µm PTFE syringe filter if particulates persist and compound recovery is acceptable.
  • Aliquot into low-bind tubes or sealed microplates to avoid repeated freeze–thaw; label with concentration, solvent, date, and lot.

Assay dosing (example framework):

  • Add stock to assay buffer or media to achieve the desired final concentration with ≤0.1–0.5% DMSO. Include a matched vehicle control and a reference standard where applicable.
  • Mix gently and pre-incubate if required by the assay design (e.g., 10–30 min) to achieve equilibrium.

Analytical QC (optional but recommended):

  • Confirm working solution concentration by LC–UV or qNMR where critical. Monitor for precipitation over the assay time course.

These are general guidelines, not validated for this specific item. Adjust based on empirical solubility/stability and your assay’s constraints.

Biological Roles

No biological target, pathway, or mode-of-action information is provided for this item in the product data. Accordingly, no item-specific biological role can be described.

General considerations for small molecules in research:

  • Small molecules may serve as chemical probes to modulate enzyme activity, protein–protein interactions, receptors, or signaling pathways in vitro. Any such role for this product would require independent validation by the user.
  • Prior to assigning a biological role, determine compound identity and purity (LC–MS, NMR), then perform concentration–response experiments with appropriate positive/negative controls and orthogonal readouts.
  • Evaluate off-target liabilities and aggregation artifacts, for example by using counter-screens, colloidal-aggregation controls (detergent tests), and thermodynamic/biophysical assays (DSF, ITC, SPR) as appropriate.
  • Confirm stability in the assay matrix (e.g., serum-containing media vs. defined buffer) to ensure the observed effect is compound-driven rather than degradation-driven.

Important note:

  • The product is labeled for research use only. It is not intended for diagnostic, therapeutic, or in vivo use. Do not infer pharmacology or efficacy from the product name; consult primary literature and generate internal data before concluding on any biological function.
Buffer Applications

This product is a small molecule and is not a buffering agent. No item-specific pKa or buffer capacity data are provided.

General guidance for using small molecules in buffered systems:

  • Prepare concentrated stocks in DMSO or another suitable solvent, then dilute into the desired buffer (e.g., PBS, HEPES, Tris) with thorough mixing to prevent local supersaturation.
  • Keep final organic co-solvent low (commonly ≤0.1–0.5% v/v) to maintain protein/enzyme stability and avoid assay interference. Always include vehicle controls.
  • If the compound is ionizable (unknown here), buffer pH may influence solubility and apparent activity. Consider testing nearby pH values (±0.5–1.0 pH units) within your assay’s tolerance.
  • For low-solubility compounds, consider adding a small amount of nonionic surfactant (e.g., 0.01–0.03% Tween 20) or cyclodextrin (e.g., 1–5 mM HP‑β‑CD) while validating that these excipients do not alter assay readouts.
  • Filter sterilization (0.22 µm) of aqueous working solutions can remove particulates, but confirm compound recovery as some analytes adsorb to filters.

Because no physicochemical data are provided for this specific item, optimize buffer choice and preparation empirically and document conditions for reproducibility.

Green Alternatives

Item-specific synthesis and solvent usage are not provided. For handling and assay preparation of small molecules, greener choices often concern solvent selection and waste minimization.

Greener dissolution strategies (general):

  • Prefer ethanol or isopropanol over DMF/NMP when solubility permits, due to lower toxicity and improved environmental profiles.
  • Use the minimum feasible DMSO concentration (e.g., ≤0.1–0.5% v/v in assays) and keep a consistent vehicle control to maintain data quality.
  • Implement microvolume stock preparation and aliquoting to reduce solvent waste and freeze–thaw cycles.

Illustrative comparison (general; not item-specific):

  • DMSO: Broad solvency; moderate environmental impact; biologically tolerated at low %.
  • Ethanol: Renewable feedstock potential; good safety profile; limited solvency for highly lipophilic compounds.
  • Isopropanol: Similar to ethanol; slower evaporation than ethanol.
  • DMF/NMP: Strong solvency but higher toxicity/regulatory burdens; use only if necessary and capture waste appropriately.

Operational green practices:

  • Use sealed 96/384-well plates for storage to minimize volatilization and emissions.
  • Consolidate wash/conditioning steps to reduce solvent volumes in LC/UPLC-based QC.
  • Segregate halogenated from non-halogenated waste to enable improved downstream treatment.

These recommendations are general. Select solvents and workflows based on actual solubility/stability data for this specific item.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation information is provided. This product is designated for research use only.

Context and limitations:

  • Not specified for this item; refer to CoA/Spec Sheet for any quality statements. Absent GMP documentation, this material is not intended for human or veterinary use, clinical trials, or commercial drug manufacturing.
  • There are no item-specific data regarding impurity profiles, residual solvents, elemental impurities, or bioburden/endotoxin—parameters typically required for pharmaceutical applications.

Laboratory formulation notes (general research context only):

  • If preparing in vitro dosing solutions, use DMSO or ethanol stock solutions and dilute into isotonic buffers or cell culture media while maintaining low solvent percentages and including vehicle controls.
  • For pre-formulation research (in vitro only), solubility can sometimes be improved with pH adjustment, cosolvents, or cyclodextrins; all such conditions must be validated for stability.

Regulatory reminder:

  • This product is not approved as an API, excipient, or diagnostic reagent. No clinical, therapeutic, or efficacy claims should be inferred or made.
Physical Properties

Item-specific physical constants and solution properties are not provided.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting/boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa(s): Not specified for this item; refer to CoA/Spec Sheet.
  • UV/Vis characteristics or refractive index: Not specified for this item; refer to CoA/Spec Sheet.

General guidance for small molecules (literature/practice):

  • Initial solubility screening commonly starts with an aprotic polar solvent (DMSO), followed by DMF, ethanol, or isopropanol. Evaluate aqueous compatibility via serial dilution into buffered media (e.g., PBS, HEPES) with gentle vortex/sonication.
  • If ionizable, solubility can improve by pH adjustment (acidic drugs in basic media; basic drugs in acidic media). Use minimal co-solvent to maintain assay compatibility.
  • For UV detection during QC, start with 210–254 nm; if aromatic chromophores are suspected, 254–280 nm can be informative (general guidance; not item-specific).
  • Hygroscopicity, photolability, or volatility are unknown for this item. Handle under ambient to low moisture and limit light exposure until specific data are available.

Always rely on the product’s CoA/Spec Sheet for authoritative, lot-specific property data.

Quality and Grades

Item-specific grade/purity information is not provided in the product data.

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Context for library/screening compounds (general):

  • Library compounds are commonly supplied at ≥95% purity by HPLC/UPLC, but required thresholds vary by application (e.g., early screening vs. lead optimization). Without explicit data, do not assume a specific purity.
  • Identity/purity verification methods often include LC–MS (electrospray), HPLC with diode array detection, and 1H NMR. The CoA typically states the analytical method, solvent system, wavelength(s), and purity basis (area % vs. weight %).
  • If low-UV impurities could impact bioassays, pair UV detection with MS or ELSD. For stereochemically complex compounds, consider chiral HPLC to assess enantiomeric/diastereomeric purity.
  • If trace water or residual solvents are critical for your work, request Karl Fischer and residual solvent data. Absent item-specific specs, perform in-house checks (KF, GC headspace) as needed.
  • For quantitative biology/biophysics, prepare a calibration standard by weighing under controlled humidity and confirming concentration by UV or quantitative NMR (qNMR) when feasible.

Recommendation:

  • Review the item’s CoA/Spec Sheet for the definitive purity grade, analytical methods, and acceptance criteria for your lot.
Reaction and Applications

Based on the category (small molecules/compound library) and the absence of structural information, this product is best considered a screening/chemical probe candidate rather than a general-purpose synthetic reagent. No item-specific reactivity or transformation data are provided in the product data.

Likely application domain (general for library compounds):

  • Biochemical and cell-based screening to explore structure–activity relationships (SAR) once the molecular identity and target context are established by the user.
  • Assay development and positive/negative control benchmarking after internal validation.
  • Target deconvolution workflows (e.g., chemoproteomics or thermal shift assays) if the compound is later shown to have tractable activity; such uses require orthogonal confirmation and are not specified for this item.

Not typically applicable:

  • Without known functional groups or stability profile, there is no basis to recommend use in named organic reactions (e.g., cross-coupling, condensations). Treat this item as a final small molecule rather than a building block.

Practical recommendations:

  • Establish a solubility/stability profile in your intended assay buffer and temperature range.
  • Validate concentration by LC–UV or qNMR for quantitative studies.
  • Evaluate nonspecific aggregation using detergent-sensitive assays or dynamic light scattering to avoid false positives in screening.

All uses are for research only; consult the CoA/SDS for specifics before designing experiments.

Reaction Conditions

No reaction conditions can be prescribed for this item due to the absence of structural and reactivity information.

General notes (if chemical modification is later pursued by the user):

  • Select solvents and temperatures that are compatible with the functional groups present in the confirmed structure. Start with mild conditions and scale cautiously.
  • For base/acid sensitivity, perform micro-scale tests (e.g., 5–10 mg) across pH 2–10 and monitor by LC–MS to define stability windows.
  • If metal-catalyzed steps are envisioned (e.g., cross-coupling), verify the presence of suitable handles (aryl halides, boronates, vinyl groups) and screen ligands/catalysts under inert atmosphere if needed.
  • For amide couplings, choose carbodiimide or uronium reagents matched to the compound’s sterics/electronics; monitor epimerization if stereocenters exist.

Because none of the above is item-specific, rely on empirical scouting aligned to the actual, verified structure. For this product as supplied, use-as-received in biological screening is the typical pathway.

Safety and Handling

Hazard classification for this specific item is not supplied in the product data. Treat as a potentially hazardous research chemical and follow prudent laboratory practices.

  • GHS classification/pictograms: Not specified for this item; refer to SDS.
  • Signal word / H‑statements: Not specified for this item; refer to SDS.

General precautions:

  • Use in a chemical fume hood. Avoid inhalation, ingestion, and contact with skin/eyes. Wear appropriate PPE: lab coat, safety glasses, and chemical-resistant gloves (e.g., nitrile). Change gloves regularly when handling DMSO stocks, as DMSO can enhance dermal absorption.
  • Storage incompatibilities are unknown. Keep segregated from strong oxidizers and acids/bases until compatibility is verified. Avoid sources of ignition if the compound or solvents are flammable.
  • First aid (overview; defer to SDS): If on skin, wash with soap/water; if in eyes, rinse with water for 15 minutes and seek medical attention; if inhaled, move to fresh air; if ingested, seek medical attention and do not induce vomiting unless instructed by medical personnel.
  • Spill/leak: Absorb with inert material, collect in a suitable container for disposal. Decontaminate area with appropriate solvent/detergent.
  • Waste: Dispose according to institutional and local regulations for organic laboratory chemicals.

Storage conditions (from Product Data):

  • Store at −20°C. Keep container tightly closed. Protect from moisture and light as a precaution. Shipments are on ice with ice pads; promptly return to cold storage upon receipt.
Solvent Selection

No item-specific solubility data are provided. The following is general guidance for small-molecule dissolution and assay compatibility.

  • Primary stock solvent: DMSO is typically the first choice due to broad solvating power and assay compatibility at ≤0.1–1% v/v final concentration (literature practice). Prepare concentrated stocks (e.g., 10–50 mM) to minimize delivered DMSO.
  • Secondary options: DMF, NMP, ethanol, or isopropanol can be used if DMSO solubility is limited. Validate biological assay tolerance for each co-solvent.
  • Aqueous use: To achieve aqueous working solutions, dilute DMSO stocks into buffered saline (e.g., PBS, HEPES). Add stock slowly with mixing to avoid local supersaturation and precipitation. Include a consistent vehicle control.
  • pH-mediated solubility: If the analyte is an acid/base, modest pH adjustment (e.g., pH 3–4 for basic amines; pH 8–9 for carboxylic acids) may enhance solubility. Avoid extreme pH unless compatible with your assay.
  • Surfactants/excipients (biology-facing workflows): 0.01–0.05% nonionic surfactants (e.g., Tween 20, Pluronic F‑127) can reduce aggregation; confirm they do not perturb readouts.

Quick selection matrix (general):

  • High hydrophobicity suspected: DMSO > DMF/NMP > ethanol.
  • Moderate polarity: DMSO or ethanol/isopropanol.
  • Salt-form compounds: Water/buffer after confirming pH stability.

Always confirm solubility and stability experimentally for this specific item.

Storage and Reconstitution

Storage conditions (from Product Data):

  • Store at −20°C. Shipped with ice chest and ice pads. Upon receipt, promptly return to −20°C storage.

General best practices for small molecules:

  • Protect from moisture and light until item-specific stability is known. Consider storing under inert gas (e.g., nitrogen) and with desiccant, especially for hygroscopic or air-sensitive compounds (unknown here).
  • Keep container tightly closed. Equilibrate to room temperature in a desiccator before opening to minimize condensation.
  • Aliquot solid or stock solutions to minimize freeze–thaw cycles. For DMSO stocks, store in amber vials or plates sealed with solvent-resistant caps/films.

Reconstitution (general guidance, not item-specific):

  • Start with DMSO at a target stock concentration (e.g., 10–50 mM). If insoluble, incrementally add compatible co-solvent (DMF, ethanol) or gently warm (≤37°C) and sonicate briefly. Do not overheat.
  • For aqueous working solutions, dilute the organic stock slowly into buffer with mixing to avoid precipitation. Verify clarity visually; if necessary, pass through a 0.22 µm PTFE filter, checking for analyte loss.

Stability notes:

  • No item-specific shelf-life or stability data are available. Verify stability by periodic LC–MS/HPLC checks under your storage conditions. Prepare fresh working solutions as needed and discard if precipitation, discoloration, or degradation is observed.

Always consult the CoA and SDS for lot-specific instructions.

Structure and Identity

Overview: CDK-TCIP2 is listed as a small-molecule/compound-library entry. Item-specific structural identifiers are not provided in the product data.

  • Chemical name: Not specified for this item; refer to CoA/Spec Sheet.
  • CAS: C1425528 (catalog placeholder; not a standard CAS Registry Number)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • Synonyms/aliases: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general note):

  • The 2D/3D structure, functional groups, ring systems, and stereochemical information are not provided in the product data. Without these, no structure-derived reactivity or property predictions can be asserted for this specific item.

Identity verification guidance (general):

  • For library compounds, identity is commonly confirmed by LC–MS (accurate mass), 1H/13C NMR, and HPLC/UPLC purity profiling. Where available, consult the item’s Certificate of Analysis (CoA) for spectral data, retention times, and purity methods.
  • If you receive a dry solid, a quick LC–MS using a generic gradient (e.g., 5–95% MeCN/H2O with 0.1% formic acid) is a practical identity/purity check. For liquids or oils, acquire 1H NMR in a deuterated solvent (e.g., DMSO‑d6 or CDCl3) as a rapid orthogonal verification.
  • If the compound is intended for screening, consider storing a reference spectrum and chromatographic trace to track lot-to-lot consistency.
Synthetic Utility

The product data do not provide a structure, functional groups, or reactivity profile. Consequently, no item-specific synthetic applications can be recommended.

General considerations:

  • Library compounds supplied for screening are typically final molecules rather than building blocks for further synthesis. They are usually employed as received for biological evaluation.
  • Without knowledge of reactive handles (e.g., halides, boronates, aldehydes, amines, carboxylic acids), guidance on cross-coupling, condensations, or derivatization is not appropriate.

If users intend to derivatize this molecule (general advice):

  • Obtain full structural information, then evaluate chemoselectivity and protecting-group strategies based on identified functional groups.
  • Establish stability domains (pH, temperature, oxidants/reductants) by small-scale stress testing prior to any transformation.
  • Use orthogonal analytics (LC–MS, NMR, HRMS) to confirm identity and purity after modification.

Given the lack of item-specific data, treat this product primarily as a screening compound rather than a synthetic intermediate.

Target Specificity

No target, binding partner, or selectivity profile is provided in the product data for this item.

  • Target/antigen: Not specified for this item; refer to CoA/Spec Sheet or primary literature if available.
  • Activity/IC50/Ki: Not specified for this item; refer to CoA/Spec Sheet.
  • Off-targets/counterscreens: Not specified for this item; refer to CoA/Spec Sheet.

Guidance (general):

  • If used as a putative chemical probe, characterize activity across a relevant panel and include orthogonal assays to confirm on-target effects.
  • Report concentration–response curves with appropriate statistics, and verify that observed effects are not due to aggregation or assay interference.

No claims regarding specificity or selectivity should be inferred from the product name alone.

Domande frequenti

How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is C1425528, the molecular formula is C52H67ClN12O8S2, and the molecular weight is 1087.75 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.